Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Jun 10;42(5):559-60.
doi: 10.1016/j.molcel.2011.05.017.

A SirT'N repression for Notch

Affiliations
Comment

A SirT'N repression for Notch

Katherine A Jones. Mol Cell. .

Abstract

Mulligan et al. (2011) show here that the NAD(+)-dependent SIRT1 (H4K16; H1K26) deacetylase acts in concert with the LSD1 (H3K4) demethylase to repress Notch-induced transcription, thus coupling two distinct histone modifications at a key epigenetic switch for Notch target genes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Model of Notch-Regulated Transcription at Target Gene Core Promoters
(A) Corepressors targeted to CSL-bound promoters in the absence of Notch signaling (left) includes SirT1, LSD1, CtBP, Co-REST, and EHMT. Other factors that contribute to Notch repression include the Rpd3:LID:Sin3A and SMRT:HDAC1 complexes, Cir-1, and SHARP. Upon signaling (right), the NICD interacts directly with CSL, Mastermind (MAML), and SKIP. Notch transactivation also requires H2B ubiquitylation and the PAF1 complex. (B) An epigenetic switch is created downstream of H2Bub at MLL1-dependent core promoters. The H3K4me3 and H4K16ac modification are “written” jointly by the physically interacting MLL1 and hMOF complexes, “read” through binding of the BPTF NURF nucleosome remodeling factor complex subunit, and “erased” in tandem, through the concerted actions of the SirT1-LSD1 corepressor complex. Other factors that bind these modified histones are mentioned in the text.

Comment on

References

    1. Bray S, Bernard F. Curr Top Dev Biol. 2010;92:253–275. - PubMed
    1. Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, Wysocka J, Allis CD, Chait BT, Hess JL, Roeder RG. Cell. 2005;121:873–885. - PubMed
    1. Guarani V, Deflorian G, Franco CA, Krüger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MH, et al. Nature. 2011;473:234–238. - PMC - PubMed
    1. Moshkin YM, Kan TW, Goodfellow H, Bezstarosti K, Maeda RK, Pilyugin M, Karch F, Bray SJ, Demmers JA, Verrijzer CP. Mol Cell. 2009;35:782–793. - PubMed
    1. Mulligan P, Yang F, Di Stefano L, Ji J-Y, Ouyang J, Nishikawa JL, Toiber D, Kulkarni M, Wang Q, Najafi-Shoushtari SH, et al. Mol Cell. 2011;42:689–699. this issue. - PMC - PubMed

LinkOut - more resources